Patient-reported quality of life (QoL) of advanced melanoma patients in a phase 3 study of nivolumab (NIVO) with or without ipilimumab (IPI) versus IPI: CheckMate 067 4-year data Meeting Abstract


Authors: Schadendorf, D.; Larkin, J. M. G.; Wolchok, J. D.; Chiarion-Sileni, V.; Taylor, F.; Lawrance, R.; Moreno-Koehler, A.; Lord-Bessen, J.; Rizzo, J. I.; Moshyk, A.; Kotapati, S.; Hodi, F. S.
Abstract Title: Patient-reported quality of life (QoL) of advanced melanoma patients in a phase 3 study of nivolumab (NIVO) with or without ipilimumab (IPI) versus IPI: CheckMate 067 4-year data
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 520s
Language: English
ACCESSION: WOS:000487345806605
DOI: 10.1200/JCO.2019.37.15_suppl.9551
PROVIDER: wos
Notes: Meeting Abstract: 9551 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok